|
ENSC Ensysce Biosciences Inc 1716947 |
| Income Statement |
|
Revenue
|
form10-k
|
3,418,853 |
|
Net Income
|
form10-k
|
661,769 |
|
Profit Margin
|
|
19.36% |
| Balance Sheet |
|
Current Assets
|
9,090,507 |
|
Assets
|
9,384,724 |
|
Current Liabilities
|
2,801,784 |
|
Liabilities
|
2,804,997 |
|
Equity
|
6,579,727 |
|
Shares Out
|
11,308,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-6,738,610 |
| Market Analysis |
Market Cap
|
3,909,870 |
|
Price
|
3.55 |
|
BVPS
|
0.58 |
|
PB
|
6.48 |
|
EPS
|
-2.98 |
|
PS
|
0.29 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENSC documents filed with the SEC.
ENSC Filings
Clear
